IRADIMED CORP 8-K

What Happened

• IRADIMED Corporation announced and furnished a press release reporting its financial results for the quarter ended December 31, 2025. The press release was issued and filed with the SEC on February 10, 2026 as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing: Form 8-K dated February 10, 2026, reporting results of operations and financial condition (Item 2.02).
• Period reported: Quarter ended December 31, 2025.
• Exhibit: Press release announcing the quarterly results is furnished as Exhibit 99.1 to the 8‑K.
• Signature: Report signed by John Glenn, Chief Financial Officer, on behalf of IRADIMED Corporation.

Why It Matters

• This 8-K signals that IRADIMED has released its latest quarterly earnings and related financial metrics (revenue, earnings, cash flow, etc.) — key information investors use to assess company performance.
• The Form 8-K itself furnishes the press release but does not restate the financial figures in the filing text; review Exhibit 99.1 (the press release) for the specific numbers, commentary, and any management remarks.
• Timely review of the press release can help investors evaluate recent results relative to expectations and any short-term impact on the stock.